1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Vicinal halo-trifluoromethylation of alkenes

      review-article
      , , , ,
      RSC Advances
      The Royal Society of Chemistry

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Both trifluoromethyl and halide groups are widely found in medicinally and pharmaceutically important compounds and, moreover, organohalides are commonly used as versatile intermediates in synthetic organic chemistry. Due to their prevalence and easy accessibility, alkene halo-trifluoromethylation provides a convenient way to install these valuable functionalities in complex targets. In this review, we summarize recent advances and achievements in this fast-growing research field. For clarity, the reactions were classified according to the type of halogen atom.

          Abstract

          Both trifluoromethyl and halide groups are widely found in medicinally and pharmaceutically important compounds and, moreover, organohalides are commonly used as versatile intermediates in synthetic organic chemistry.

          Related collections

          Most cited references86

          • Record: found
          • Abstract: not found
          • Article: not found

          Fluorine in pharmaceutical industry: fluorine-containing drugs introduced to the market in the last decade (2001-2011).

            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Aromatic trifluoromethylation with metal complexes.

              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II-III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas.

                Bookmark

                Author and article information

                Journal
                RSC Adv
                RSC Adv
                RA
                RSCACL
                RSC Advances
                The Royal Society of Chemistry
                2046-2069
                21 April 2021
                21 April 2021
                21 April 2021
                : 11
                : 25
                : 14941-14955
                Affiliations
                [a] Department of Chemistry, College of Science, University of Bu Ali Sina Hamadan Iran
                [b] College of Health Sciences, University of Human Development Sulaimaniyah Kurdistan region of Iraq
                [c] Department of Chemistry, North Tehran Branch, Islami Azad University P.O. Box: 1913674711 Tehran Iran mb_esnaashari@ 123456yahoo.com
                [d] Department of Agriculture, Jouybar Branch, Islamic Azad University Jouybar Iran
                [e] Department of Chemistry, Payame Noor University P.O. Box 19395-3697 Tehran Iran
                Author information
                https://orcid.org/0000-0002-6465-7605
                Article
                d0ra06872a
                10.1039/d0ra06872a
                8698610
                35424045
                8f62973e-ba0a-419c-8ae4-141be37cbf3a
                This journal is © The Royal Society of Chemistry
                History
                : 9 August 2020
                : 23 March 2021
                Page count
                Pages: 15
                Categories
                Chemistry
                Custom metadata
                Paginated Article

                Comments

                Comment on this article